Free Trial
→ 917 Trades… Zero Losses? (From Insiders Exposed) (Ad) Free ELVN Stock Alerts

Enliven Therapeutics (ELVN) Insider Trading & Ownership

Enliven Therapeutics logo
$25.52 +0.09 (+0.35%)
(As of 11/21/2024 ET)
Compare

Enliven Therapeutics (NASDAQ:ELVN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
29.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$44.64 M
Get ELVN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enliven Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ELVN Insider Buying and Selling by Quarter

Ad DTI
I've got news for you…
Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week
watch this FREE briefing with me and expert trader Graham Lindman

Enliven Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/28/2024Benjamin HohlCFOSell6,250$28.56$178,500.00  
10/18/2024Anish PatelCOOSell716$30.00$21,480.00  
10/18/2024Benjamin HohlCFOSell814$30.00$24,420.00  
10/18/2024Joseph P LyssikatosInsiderSell847$30.00$25,410.00  
10/18/2024Richard A HeymanDirectorSell817$30.00$24,510.00  
10/18/2024Samuel KintzCEOSell924$30.00$27,720.00  
10/15/2024Richard A HeymanDirectorSell1,270$27.67$35,140.90  
10/9/2024Joseph P LyssikatosInsiderSell37,878$28.16$1,066,644.48  
10/9/2024Samuel KintzCEOSell16,710$28.15$470,386.50  
10/8/2024Rahul D BallalDirectorSell10,420$28.17$293,531.40  
10/7/2024Benjamin HohlCFOSell1,270$27.51$34,937.70  
10/7/2024Joseph P LyssikatosInsiderSell2,707$27.61$74,740.27  
10/7/2024Samuel KintzCEOSell2,730$27.50$75,075.00  
10/4/2024Benjamin HohlCFOSell10,218$27.51$281,097.18  
10/4/2024Joseph P LyssikatosInsiderSell7,522$27.51$206,930.22  
10/4/2024Richard A HeymanDirectorSell2,825$27.51$77,715.75  
10/4/2024Samuel KintzCEOSell12,206$27.51$335,787.06  
10/1/2024Joseph P LyssikatosInsiderSell527$27.54$14,513.58  
10/1/2024Richard A HeymanDirectorSell518$27.54$14,265.72  
10/1/2024Samuel KintzCEOSell526$27.54$14,486.04  
9/30/2024Benjamin HohlCFOSell2,000$25.33$50,660.00  
9/27/2024Benjamin HohlCFOSell4,250$24.27$103,147.50  
8/29/2024Joseph P LyssikatosInsiderSell12,000$22.49$269,880.00  
8/27/2024Benjamin HohlCFOSell4,250$22.54$95,795.00  
8/26/2024Samuel KintzCEOSell12,000$22.89$274,680.00  
8/15/2024Richard A HeymanDirectorSell1,270$23.25$29,527.50  
7/31/2024Benjamin HohlCFOSell991$27.53$27,282.23  
7/31/2024Joseph P LyssikatosInsiderSell3,099$27.56$85,408.44  
7/31/2024Richard A HeymanDirectorSell1,702$27.51$46,822.02  
7/31/2024Samuel KintzCEOSell2,270$27.56$62,561.20  
7/29/2024Benjamin HohlCFOSell5,250$26.68$140,070.00  
7/29/2024Joseph P LyssikatosInsiderSell12,000$26.70$320,400.00  
7/25/2024Samuel KintzCEOSell12,000$24.92$299,040.00  
7/15/2024Anish PatelCOOSell30,978$25.05$775,998.90  
7/15/2024Richard A HeymanDirectorSell1,270$24.80$31,496.00  
7/12/2024Anish PatelCOOSell17,475$25.07$438,098.25  
7/12/2024Benjamin HohlCFOSell3,000$25.07$75,210.00  
6/27/2024Benjamin HohlCFOSell4,250$22.57$95,922.50  
6/25/2024Samuel KintzCEOSell12,000$21.66$259,920.00  
6/6/2024Anish PatelCOOSell1,133$20.06$22,727.98  
With the “Bitcoin Loophole” you can help supercharge the gains by 10x or more! (Ad)

You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords… Heck, you don’t even need a crypto wallet!

>> Tap here to sign up and join them for the imminent workshop
5/28/2024Benjamin HohlCFOSell4,250$23.18$98,515.00  
5/28/2024Samuel KintzCEOSell12,000$23.18$278,160.00  
5/16/2024Rishi GuptaDirectorSell1,033,300$22.14$22,877,262.00  
5/14/2024Anish PatelCOOSell1,107$25.00$27,675.00  
5/9/2024Anish PatelCOOSell260$25.06$6,515.60  
5/6/2024Anish PatelCOOSell4,875$22.72$110,760.00  
5/3/2024Benjamin HohlCFOSell1,000$22.50$22,500.00  
4/29/2024Benjamin HohlCFOSell3,250$16.97$55,152.50  
4/29/2024Joseph P. LyssikatosinsiderSell12,000$17.92$215,040.00  
4/25/2024Samuel KintzCEOSell12,000$16.89$202,680.00  
4/15/2024Richard A HeymanDirectorSell1,270$19.99$25,387.30  
4/11/2024Anish PatelCOOSell17,500$25.03$438,025.00  
4/11/2024Benjamin HohlCFOSell14,000$24.72$346,080.00  
4/11/2024Joseph P. LyssikatosinsiderSell30,000$25.04$751,200.00  
4/11/2024Rahul D BallalDirectorSell53,400$23.95$1,278,930.00  
4/11/2024Samuel KintzCEOSell47,709$25.04$1,194,633.36  
4/8/2024Anish PatelCOOSell4,875$18.60$90,675.00  
4/4/2024Rahul D BallalDirectorSell3,485$19.15$66,737.75  
4/1/2024Joseph P. LyssikatosinsiderSell12,000$18.60$223,200.00  
4/1/2024Rahul D BallalDirectorSell3,237$19.08$61,761.96  
3/27/2024Benjamin HohlCFOSell3,250$18.25$59,312.50  
3/25/2024Samuel KintzCEOSell12,000$17.56$210,720.00  
3/19/2024Richard A HeymanDirectorSell1,270$14.50$18,415.00  
3/6/2024Anish PatelCOOSell4,875$15.64$76,245.00  
2/29/2024Joseph P. LyssikatosinsiderSell12,000$16.42$197,040.00  
2/27/2024Benjamin HohlCFOSell3,250$16.97$55,152.50  
2/15/2024Richard A HeymanDirectorSell1,270$17.42$22,123.40  
2/6/2024Anish PatelCOOSell4,875$15.11$73,661.25  
1/31/20245Am Partners Vi, LlcMajor ShareholderSell500,000$15.00$7,500,000.00  
1/30/2024Richard A HeymanDirectorSell1,270$16.41$20,840.70  
1/29/2024Benjamin HohlCFOSell3,250$15.81$51,382.50  
1/29/2024Joseph P. LyssikatosinsiderSell12,000$15.85$190,200.00  
1/25/2024Samuel KintzCEOSell12,000$15.69$188,280.00  
1/22/2024Anish PatelCOOSell4,875$15.13$73,758.75  
1/2/2024Anish PatelCOOSell11,000$15.00$165,000.00  
1/2/2024Benjamin HohlCFOSell9,383$15.01$140,838.83  
12/26/2023Anish PatelCOOSell102$15.01$1,531.02  
12/26/2023Benjamin HohlCFOSell100$15.00$1,500.00  
12/26/2023Samuel KintzCEOSell12,000$14.64$175,680.00  
12/22/2023Anish PatelCOOSell983$15.03$14,774.49  
12/22/2023Benjamin HohlCFOSell1,030$15.07$15,522.10  
12/22/2023Samuel KintzCEOSell8,175$13.05$106,683.75  
12/21/2023Joseph P. LyssikatosinsiderSell20$13.00$260.00  
12/21/2023Richard A HeymanDirectorSell7$13.00$91.00  
12/20/2023Samuel KintzCEOSell7,779$13.01$101,204.79  
12/19/2023Joseph P. LyssikatosinsiderSell200$13.00$2,600.00  
12/19/2023Richard A HeymanDirectorSell255$13.00$3,315.00  
(Data available from 1/1/2013 forward)

ELVN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Enliven Therapeutics includes 5Am Partners Vi, Llc, Anish Patel, Benjamin Hohl, Joseph P Lyssikatos, Rahul D Ballal, Richard A Heyman, Rishi Gupta, and Samuel Kintz. Learn more on insiders at ELVN.

29.20% of Enliven Therapeutics stock is owned by insiders. Learn more on ELVN's insider holdings.

The following insiders have sold ELVN shares in the last 24 months: 5Am Partners Vi, Llc ($17,502,500.00), Anish Patel ($2,336,926.24), Benjamin Hohl ($1,952,998.04), Joseph P Lyssikatos ($2,063,926.99), Rahul D Ballal ($1,700,961.11), Richard A Heyman ($349,650.29), Rishi Gupta ($22,877,262.00), and Samuel Kintz ($4,548,397.78).

Insiders have sold a total of 2,837,692 Enliven Therapeutics shares in the last 24 months for a total of $55,187,384.13 sold.

Enliven Therapeutics Key Executives

  • Mr. Samuel S. Kintz M.B.A. (Age 38)
    Co-Founder, CEO, Secretary & Director
    Compensation: $866.41k
  • Dr. Joseph P. Lyssikatos Ph.D. (Age 59)
    Co-Founder & Chief Scientific Officer
    Compensation: $632.67k
  • Dr. Helen Louise Collins M.D. (Age 61)
    Chief Medical Officer
    Compensation: $686.19k
  • Mr. Anish Patel Pharm.D. (Age 43)
    Co-Founder & COO
  • Mr. Benjamin Hohl (Age 34)
    CFO & Head of Corporate Development
    Compensation: $488.5k
    12 recent trades
  • Dr. Galya D. Blachman Esq. (Age 47)
    Ph.D., Chief Legal Officer & Head of Business Development

Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:ELVN) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners
[Urgent] Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...
Paradigm Press | Sponsored
Buffett Dumps $982 Million in BofA Stock—What Does He Know?
Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...
Genesis Gold Group | Sponsored
Central Bank Abandons USD
You know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...
Desko Digital | Sponsored
America’s Pro-Crypto Agenda
Cash In On the Pro-Crypto America 27 experts reveal their top picks for 2025
Crypto 101 Media | Sponsored
A “Thank You Gift” From Pres. Trump - Genius
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...
Colonial Metals | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...
Crypto Swap Profits | Sponsored
Elon Musk’s chilling warning for humanity
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...
The Freeport Society | Sponsored